The study’s goal was to create and test buccal-adhesive tablets of Buspirone HCl that avoid gastric degradation and first pass metabolism, increasing drug bioavailability and onset of action. Buspirone HCl is an anxiolytic agent as well as a serotonin receptor agonist from the azaspirodecanedione class of compounds. Methods: In...